coronaviru
diseas
rapidli
emerg
global
pandem
viral
infect
involv
upper
respiratori
tract
could
lead
sever
pneumonia
respiratori
distress
even
death
certain
studi
found
higher
initi
plasma
level
proinflammatori
cytokin
cours
infect
context
vitro
vivo
studi
reveal
metronidazol
could
decreas
level
sever
cytokin
known
increas
infect
includ
interleukin
il
tumor
necrosi
factor
tnf
interferon
ifn
well
level
creactiv
protein
crp
neutrophil
count
furthermor
drug
could
decreas
neutrophilgener
reactiv
oxygen
speci
inflamm
metronidazol
could
counteract
major
immunopatholog
manifest
infect
therefor
studi
larg
sampl
size
requir
determin
efficaci
metronidazol
treatment
infect
coronaviru
diseas
rapidli
emerg
global
pandem
sinc
first
report
decemb
china
infect
involv
upper
respiratori
tract
could
lead
sever
pneumonia
respiratori
distress
even
death
current
specif
treatment
avail
strategi
princip
symptomat
therefor
find
effect
econom
treatment
strategi
essenti
particularli
lifethreaten
infect
present
evid
literatur
immunolog
manifest
infect
potenti
effect
metronidazol
counteract
major
immunopatholog
featur
follow
evalu
admit
patient
laboratoryconfirm
infect
wuhan
china
huang
et
al
found
higher
initi
plasma
level
proinflammatori
cytokin
includ
interleukin
il
basic
fibroblast
growth
factor
fgf
granulocytecoloni
stimul
factor
gcsf
granulocytemacrophag
colonystimul
factor
gmcsf
interferon
ifn
induc
protein
monocyt
chemoattract
protein
macrophag
inflammatori
protein
mip
plateletderiv
growth
factor
pdgf
tumor
necrosi
factor
tnf
vascular
endotheli
growth
factor
vegf
intens
care
unit
icu
nonicu
patient
healthi
subject
howev
plasma
level
eotaxin
rant
similar
evalu
reveal
higher
plasma
level
gcsf
icuadmit
patient
nonicu
patient
chen
et
al
retrospect
evalu
patient
laboratoryconfirm
infect
report
lymphopenia
case
well
increas
level
neutrophil
erythrocyt
sediment
rate
esr
creactiv
protein
crp
case
respect
howev
whether
viru
directli
infect
immun
cell
includ
neutrophil
lymphocyt
yet
establish
zhou
et
al
conduct
retrospect
multicent
studi
patient
laboratoryconfirm
infect
report
elev
level
sever
lymphopenia
nonsurvivor
survivor
univari
analysi
data
reveal
signific
associ
lymphopenia
elev
serum
level
mortal
metronidazol
relat
redoxact
prodrug
act
biocid
agent
via
interact
nitroreductas
homolog
vitro
vivo
studi
reveal
metronidazol
decreas
level
sever
cytokin
includ
well
level
crp
neutrophil
count
interestingli
paramet
shown
increas
infect
moreov
metronidazol
could
increas
number
circulatori
lymphocyt
lymphoprolif
properti
suggest
immunopotenti
effect
immunomodulatori
effect
metronidazol
discuss
detail
previous
publish
review
shakir
et
al
furthermor
medic
could
decreas
neutrophilgener
reactiv
oxygen
speci
inflamm
tabl
summar
effect
metronidazol
immunopatholog
manifest
infect
metronidazol
owe
immunopharmacolog
behavior
play
pivot
role
sever
essenti
biolog
process
base
report
immunolog
manifest
infect
could
serv
potenti
candid
counteract
major
immunopatholog
featur
diseas
therefor
clinic
trial
larg
sampl
size
necessari
determin
efficaci
treatment
infect
metronidazol
crp
crp
neutrophil
neutrophil
lymphocyt
lymphocyt
lymphoprolif
properti
crp
creactiv
protein
ifn
interferon
il
interleukin
tnf
tumor
necrosi
factor
author
wish
thank
intern
virtual
ophthalm
research
center
ivorc
continu
academ
support
research
result
independ
research
without
financi
support
author
declar
compet
interest
exist
